share_log

Option Care Health's (NASDAQ:OPCH) Solid Profits Have Weak Fundamentals

Option Care Health's (NASDAQ:OPCH) Solid Profits Have Weak Fundamentals

Option Care Health(納斯達克股票代碼:OPCH)的穩健利潤基本面疲軟
Simply Wall St ·  04/30 06:41

Option Care Health, Inc. (NASDAQ:OPCH) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers.

Option Care Health, Inc.(納斯達克股票代碼:OPCH)宣佈了豐厚的利潤,但該股停滯不前。我們的分析表明,股東們注意到了一些令人擔憂的數字。

earnings-and-revenue-history
NasdaqGS:OPCH Earnings and Revenue History April 30th 2024
NASDAQGS: OPCH 收益和收入歷史記錄 2024 年 4 月 30 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

Importantly, our data indicates that Option Care Health's profit received a boost of US$85m in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If Option Care Health doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

重要的是,我們的數據表明,與去年相比,Option Care Health的不尋常項目利潤增加了8500萬美元。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。如果 Option Care Health 認爲這筆捐款不會重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Option Care Health's Profit Performance

我們對 Option Care Health 利潤表現的看法

Arguably, Option Care Health's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Option Care Health's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into Option Care Health, you'd also look into what risks it is currently facing. To that end, you should learn about the 3 warning signs we've spotted with Option Care Health (including 1 which can't be ignored).

可以說,Option Care Health的法定收益被提高利潤的不尋常項目所扭曲。因此,在我們看來,Option Care Health的真正潛在盈利能力實際上可能低於其法定利潤。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。如果你想更深入地研究 Option Care Health,你還需要研究它目前面臨的風險。爲此,你應該了解我們在 Option Care Health 中發現的 3 個警告信號(包括 1 個不容忽視的警告信號)。

This note has only looked at a single factor that sheds light on the nature of Option Care Health's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

本報告僅研究了揭示Option Care Health利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論